Towards a systematic nationwide screening strategy for MODY

Area of Science:

• Endocrinology
• Genetics
• Pediatrics

Background:

• Monogenic forms of diabetes, such as Maturity-Onset Diabetes of the Young (MODY), require precise genetic diagnosis for optimal treatment.
• Accurate MODY subtype identification can enable patients to discontinue unnecessary insulin therapy, improving quality of life.
• Diagnostic genetic testing for MODY is costly, necessitating effective screening strategies to select appropriate candidates.

Discussion:

• A nationwide screening approach was developed to identify pediatric patients with MODY.
• The strategy targeted individuals negative for GAD and IA-2 islet autoantibodies, effectively excluding those with Type 1 diabetes markers.
• The commentary evaluates the strengths and weaknesses of this systematic screening method.

Key Insights:

• Screening antibody-negative pediatric patients is a viable strategy for identifying MODY.
• This approach helps differentiate MODY from Type 1 diabetes in a young population.
• Careful interpretation of genetic variants is essential, especially when testing broader populations.

Outlook:

• Further refinement of screening protocols can improve MODY diagnosis efficiency.
• Wider implementation could lead to earlier and more accurate MODY management.
• Continued research is needed to address variants of uncertain significance in genetic testing.